Charming Medical Limited Class A Ordinary Shares
MCTANASDAQHealthcare
$29.36
+$1.86(+6.75%)
Market Cap$445550190
P/E Ratio—
52W High$31.7
52W Low$4.3
Charming Medical Limited Class A Ordinary Shares（MCTA）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MCTA · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-03 | 2024-03 | 2023-03 |
|---|---|---|---|
| Revenue | |||
| Revenue | $6.22M | $6.02M | $3.53M |
| Cost of Revenue | $2.04M | $2.10M | $2.04M |
| Gross Profit | $4.18M | $3.91M | $1.49M |
| Gross Margin %(computed) | 67.19% | 65.07% | 42.31% |
| Operating Expenses | |||
| R&D Expenses | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $1.32M | $1.49M | $1.00M |
| Total Operating Expenses | $2.79M | $2.91M | $2.02M |
| Operating Income | $1.39M | $1.01M | ($0.52M) |
| Operating Margin %(computed) | 22.32% | 16.77% | -14.77% |
| Interest Income | $0.06M | $0.02M | $0.01M |
| Interest Expense | $0.02M | $0.03M | $0.02M |
| Income Before Tax | $1.44M | $1.00M | ($0.42M) |
| Income Tax Expense | $0.24M | $0.18M | ($0.08M) |
| Net Income | $1.20M | $0.78M | ($0.31M) |
| Net Margin %(computed) | 19.27% | 12.93% | -8.64% |
| Per Share & EBITDA | |||
| EPS (Basic) | $0.07 | $0.05 | $-0.02 |
| Wtd Avg Shares | 16.94M | 16.94M | 16.94M |
| EBITDA | $1.72M | $1.42M | ($0.19M) |
| EBITDA Margin %(computed) | 27.64% | 23.63% | -5.36% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Charming Medical Limited Class A Ordinary Shares
关于Charming Medical Limited Class A Ordinary Shares（MCTA）损益表
Charming Medical Limited Class A Ordinary Shares（MCTA）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，MCTA实现营收$0.01B，毛利润$0.00B（毛利率67.19%），净利润$0.00B（净利率19.27%）。
常见问题
MCTA · 4 问Charming Medical Limited Class A Ordinary Shares（MCTA）2025财年营收为$0.01B，同比up3.4%。
MCTA revenueMCTA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08